Clinical Trial Update: Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

View source ↗

Summary

This document reports the completion of a comparative efficacy trial evaluating Tears Again, Opticol, and Optive for Dry Eye Syndrome. The study status is COMPL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Opticol®
• Optive
• Tears Again®

Snippet

Sponsor: Hospital de Sao Sebastiao | Conditions: Dry Eye Syndrome | Status: COMPLETED